Despite the above examples indicating that M-CSFR blockade can shift the balance in TAM subpopulations from tumor-promoting M2-oriented MHC-IIlow or MMRhigh to anti-tumoral M1-oriented MHC-IIhigh or MMRlow macrophages, conflicting reports also exist. The gene discussed is CSF1R; the disease is neoplasm.